Fig. 1
From: Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
Patient HIV-1/HIV-2/HBV viral loads and TCD4 + count over calendar time. This graphic represents the evolution of the HIV-1/HIV-2/HBV viral loads and TCD4 + count between diagnosis in 2001 and last evaluation of the patient in 2019. The curves were represented in a logarithmic scale for better understanding. Additionally we highlighted the moments when ARV was changed (white boxes) and mutations detected (black boxes). The level of detection illustrated is < 20 copies/mL for HIV-1, < 40 copies/mL for HIV-2 and < 20 copies/mL for HBV. Lamivudine (3TC), atazanavir (ATV), darunavir (DRV), dolutegravir (DTG), emtricitabine (FTC) hepatitis B virus (HBV), hepatitis B virus (HBV), human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2), lopinavir (LPV), maraviroc (MVC), nelfinavir (NFV), raltegravir (RAL), tenofovir alafenamide fumarate (TAF), tenofovir disoproxil fumarate (TDF), viral load (VL)